Form 4 for PCVX Vaxcyte, Inc.
Accepted 2022-03-03 00:00:00 ET · period of report 2022-03-01 · accession 0001209191-22-015477 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-03 | 2022-03-01 | PCVX | GUGGENHIME ANDREW | Pres, CFO | M - OptEx | $5.35 | +6,200 | 9,325 | +198% | +$33.2K |
| D | 2022-03-03 | 2022-03-01 | PCVX | GUGGENHIME ANDREW | Pres, CFO | S - Sale+OE | $24.00 | -6,200 | 3,125 | -66% | -$148.8K |
| D | 2022-03-03 | 2022-03-01 | PCVX | GUGGENHIME ANDREW | Pres, CFO | M - OptEx | $0.00 | -6,200 | 512.2K | -1% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-01 | M | A | 6,200 | $5.35 | 9,325 | D | — | — | |
| 2 | Common | Common Stock | 2022-03-01 | S | D | 6,200 | $24.00 | 3,125 | D | — | — | |
| 3 | Derivative | Stock Option (right to buy) | 2022-03-01 | M | D | 6,200 | $0.00 | 512,218 | D | $5.35 · — to 2030-05-11 | 6,200 Common Stock | (F2) 1/4 of the shares subject to the option vested on May 1, 2021, and 1/48 of the shares vest monthly thereafter. |